Kyle Reynolds, MD
Vascular Surgery · Washington, DCNPI 1417334525
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Shockwave Medical, Inc at 47.4% of the total. Among vascular surgery clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 650 payments — averaging $254.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$79K
- Boston Scientific$34K
- Stryker$18K
- Medtronic$11K
- Inari Medical, Inc.$7K
- Bard Peripheral Vascular, Inc.$4K
- plus $14K from 32 others
Across 30 payments — averaging $3908.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$45K
- Shockwave Medical, Inc$27K
- Cagent Vascular Inc$26K
- Stryker$18K
What the payments were for
- Consulting fees$43,19626%
- Speaking & faculty fees$61,36337%
- Grants$3,5002%
- Travel & lodging$32,11619%
- Food & beverage$25,41615%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 109 | $78,537 |
| Boston Scientific | 168 | $34,062 |
| Stryker | 30 | $17,925 |
| Medtronic(2 entities) | 44 | $10,683 |
| Inari Medical, Inc. | 59 | $6,628 |
| Bard Peripheral Vascular, Inc. | 23 | $3,572 |
| Endologix LLC | 20 | $3,452 |
| Cook Incorporated | 1 | $2,500 |
| Cook Medical LLC | 47 | $1,725 |
| Abbott | 34 | $1,596 |
| Philips North America LLC | 31 | $1,185 |
| Cagent Vascular Inc | 7 | $635 |
| Tactile Systems Technology Inc | 21 | $436 |
| Reflow Medical Inc | 1 | $368 |
| Silk Road Medical, Inc. | 4 | $307 |
| Bolton Medical Inc | 4 | $296 |
| Organogenesis Inc. | 6 | $265 |
| Cardiovascular Systems Inc. | 4 | $205 |
| Veryan Medical Incorporated | 2 | $150 |
| Terumo Medical Corporation | 2 | $140 |
| W. L. Gore & Associates, Inc. | 3 | $111 |
| Nipro Medical Corporation | 1 | $83 |
| Angiodynamics, Inc. | 3 | $83 |
| Cashflow Solutions, LLC | 4 | $78 |
| Kerecis Limited | 5 | $71 |
| Polymedics Innovations Inc. | 2 | $69 |
| Johnson & Johnson | 2 | $58 |
| Amgen | 1 | $50 |
| Novo Nordisk | 1 | $50 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $50 |
| BD | 2 | $48 |
| Artivion, Inc. | 1 | $41 |
| Cordis US CORP. | 2 | $35 |
| Inspiremd Ltd | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Sanara Medtech Inc. | 1 | $17 |
| Lemaitre Vascular, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$75,119
- CT THROMBECTOMY SYSTEM KIT$21,339
- FLOWTRIEVER CATHETER, S$21,178
- GENERAL - THERAPIES$10,433
- Ranger$5,563
- IN.PACT Admiral$4,651
- Endurant$3,500
- Zilver PTX$2,914
- Vascular Lithotripsy$2,100
- ELUVIA$1,842
- ENDOCROSS Device$1,336
- Torus Stent Graft System$1,336
- ENDURANT IIS$1,188
- ARTIX MT$573
- Serrantor$542
- FlowTriever$448
- ClotTriever$448
- Supera peripheral stent system$391
- RotarexS 6 F x 135 cm$333
- Zenith Alpha$330
How this compares
$165,591 in reported general payments places this provider in the 90th percentile of 24 vascular surgery providers in District of Columbia.
See all vascular surgery providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $13,337 |
| ClopidogrelClopidogrel Bisulfate | 26 | $218 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Washington
- Steven AbramowitzWashington$722K
- Misaki KiguchiWashington$187K
- Yang YangWashington$68K
- Danielle SalazarWashington$20K
- Salim LalaWashington$10K
- Abdullah AlfawazWashington$10K
- D'andre WilliamsWashington$9K
- Robyn MacsataWashington$5K
- Frederick BeaversWashington$5K
- Rodeen RahbarWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.